Market Cap 88.69M
Revenue (ttm) 74.89M
Net Income (ttm) -43.71M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -58.37%
Debt to Equity Ratio 2.09
Volume 8,648,500
Avg Vol 2,077,676
Day's Range N/A - N/A
Shares Out 68.49M
Stochastic %K 65%
Beta 0.87
Analysts Strong Sell
Price Target $6.50

Company Profile

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific area...

Industry: Medical Devices
Sector: Healthcare
Phone: 610 640 4202
Fax: 610 640 4206
Address:
3222 Phoenixville Pike, Malvern, United States
SellHoldBuy
SellHoldBuy Mar. 17 at 6:41 PM
$STIM New ceo looks strong. This will go up. Weird day after positive results.
0 · Reply
Dou_said_it
Dou_said_it Mar. 17 at 4:06 PM
$STIM i don t know what tondo in yhis case lol: Hold because good results / Sell because Shorts and it can go down soon
0 · Reply
ejz92
ejz92 Mar. 17 at 2:25 PM
$STIM Easy money on manipulated drop. Let’s burn the shorts!
0 · Reply
1SwingSensei
1SwingSensei Mar. 17 at 2:06 PM
$STIM Outrageous head fake, deep red to green. If you're not bullish & or didn’t buy the dip, shame on you!🫠
1 · Reply
Fillorkill7
Fillorkill7 Mar. 17 at 1:59 PM
$STIM imagine being short one of the most shorted name on the planet and it opens down 25%, and it finishes the day up 100%. Could be fun to watch. $GME $AMC $BYND $OPEN
0 · Reply
CranialRocK
CranialRocK Mar. 17 at 1:46 PM
$STIM HOLDING AND PUSHING!
1 · Reply
Alex1m2
Alex1m2 Mar. 17 at 1:42 PM
0 · Reply
Alex1m2
Alex1m2 Mar. 17 at 1:41 PM
$STIM they threw it down over 40 %, lol so iliquid
0 · Reply
CranialRocK
CranialRocK Mar. 17 at 1:38 PM
$STIM SICKNING
0 · Reply
ejz92
ejz92 Mar. 17 at 1:38 PM
$STIM WTH?? Numbers were not that bad?
0 · Reply
Latest News on STIM
Neuronetics, Inc. (STIM) Q4 2025 Earnings Call Transcript

Mar 17, 2026, 1:12 PM EDT - 20 hours ago

Neuronetics, Inc. (STIM) Q4 2025 Earnings Call Transcript


Neuronetics, Inc. (STIM) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 12:26 PM EST - 4 months ago

Neuronetics, Inc. (STIM) Q3 2025 Earnings Call Transcript


Neuronetics, Inc. (STIM) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 12:53 PM EDT - 8 months ago

Neuronetics, Inc. (STIM) Q2 2025 Earnings Call Transcript


Neuronetics Appoints New Chief Financial Officer

Jul 15, 2025, 7:30 AM EDT - 8 months ago

Neuronetics Appoints New Chief Financial Officer


Neuronetics, Inc. (STIM) Q1 2025 Earnings Call Transcript

May 6, 2025, 9:57 AM EDT - 11 months ago

Neuronetics, Inc. (STIM) Q1 2025 Earnings Call Transcript


Neuronetics, Inc. (STIM) Q4 2024 Earnings Call Transcript

Mar 4, 2025, 9:52 AM EST - 1 year ago

Neuronetics, Inc. (STIM) Q4 2024 Earnings Call Transcript


Neuronetics and Greenbrook TMS Announce Closing of Transaction

Dec 10, 2024, 10:00 AM EST - 1 year ago

Neuronetics and Greenbrook TMS Announce Closing of Transaction


Neuronetics, Inc. (STIM) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 8:41 PM EST - 1 year ago

Neuronetics, Inc. (STIM) Q3 2024 Earnings Call Transcript


Neuronetics, Inc. (STIM) Q2 2024 Earnings Call Transcript

Aug 12, 2024, 1:59 PM EDT - 1 year ago

Neuronetics, Inc. (STIM) Q2 2024 Earnings Call Transcript


SellHoldBuy
SellHoldBuy Mar. 17 at 6:41 PM
$STIM New ceo looks strong. This will go up. Weird day after positive results.
0 · Reply
Dou_said_it
Dou_said_it Mar. 17 at 4:06 PM
$STIM i don t know what tondo in yhis case lol: Hold because good results / Sell because Shorts and it can go down soon
0 · Reply
ejz92
ejz92 Mar. 17 at 2:25 PM
$STIM Easy money on manipulated drop. Let’s burn the shorts!
0 · Reply
1SwingSensei
1SwingSensei Mar. 17 at 2:06 PM
$STIM Outrageous head fake, deep red to green. If you're not bullish & or didn’t buy the dip, shame on you!🫠
1 · Reply
Fillorkill7
Fillorkill7 Mar. 17 at 1:59 PM
$STIM imagine being short one of the most shorted name on the planet and it opens down 25%, and it finishes the day up 100%. Could be fun to watch. $GME $AMC $BYND $OPEN
0 · Reply
CranialRocK
CranialRocK Mar. 17 at 1:46 PM
$STIM HOLDING AND PUSHING!
1 · Reply
Alex1m2
Alex1m2 Mar. 17 at 1:42 PM
0 · Reply
Alex1m2
Alex1m2 Mar. 17 at 1:41 PM
$STIM they threw it down over 40 %, lol so iliquid
0 · Reply
CranialRocK
CranialRocK Mar. 17 at 1:38 PM
$STIM SICKNING
0 · Reply
ejz92
ejz92 Mar. 17 at 1:38 PM
$STIM WTH?? Numbers were not that bad?
0 · Reply
RedLeader2
RedLeader2 Mar. 17 at 1:37 PM
$STIM the short selling shit is just ruining the market for everyone
0 · Reply
Davidoct1405
Davidoct1405 Mar. 17 at 1:23 PM
$STIM clearly worth more than $1.25.
0 · Reply
eznoeffortgunner
eznoeffortgunner Mar. 17 at 1:07 PM
$STIM womp womp
0 · Reply
Davidoct1405
Davidoct1405 Mar. 17 at 1:07 PM
$STIM such good numbers but poor performance this morning. Seems like it will probably turn around at open. How couldn’t it?
0 · Reply
StockNews_Live
StockNews_Live Mar. 17 at 12:19 PM
$STIM 🎯 STOCK NEWS ALERT 💵 Price: $1.38 (+5.02%) 🔥 Sentiment Score: 85/100 🚀 VERY POSITIVE NEWS 📄 Neuronetics, Inc. announced its financial and operating results for the fourth quarter and full year of 2025. The company reported revenue of $41.8 million in Q4 2025, up 86% as reported and 23% on… 📎 https://stocknews.live/news/STIM/neuronetics-reports-fourth-quarter-48258.html
0 · Reply
StockNews_Live
StockNews_Live Mar. 17 at 12:17 PM
$STIM 🎯 STOCK NEWS ALERT 💵 Price: $1.38 (+5.02%) 🔥 Sentiment Score: 85/100 🚀 VERY POSITIVE NEWS 📄 Neuronetics, Inc. announced the appointment of Dan Reuvers as the Company's next President and Chief Executive Officer, effective March 23, 2026. Mr. Reuvers brings more than 30 years of medical… 📎 https://stocknews.live/news/STIM/neuronetics-appoints-dan-reuvers-03599.html
0 · Reply
CranialRocK
CranialRocK Mar. 17 at 12:16 PM
$STIM THINK THIS IS THE PROBLEM?
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 17 at 12:04 PM
$STIM Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.10 up 70.59% YoY • Reported revenue of $41.78M up 85.73% YoY • Neuronetics anticipates operating losses will continue in the near term, but management believes cash and anticipated revenues are sufficient to fund operations for at least the next 12 months; U.S. revenue is expected to increase.
0 · Reply
topstockalerts
topstockalerts Mar. 17 at 12:01 PM
$STIM keep an eye on it for today
0 · Reply
DonCorleone77
DonCorleone77 Mar. 17 at 11:56 AM
$STIM Neuronetics appoints Dan Reuvers as President and CEO Neuronetics appointed Dan Reuvers as the company's next President and CEO, effective March 23. Reuvers will also join the Board of Directors at that time. He succeeds Keith Sullivan, who will step down as the company's President and CEO on March 23 and retire on March 31 after five and a half years of leading the company. Reuvers most recently served as President and CEO of Tactile Medical. Prior to Tactile Medical, Reuvers spent 12 years at Integra LifeSciences, rising to Executive Vice President and President of Codman Specialty Surgical, a $1B global neurosurgery division. Earlier in his career, he held leadership roles at Omni-Tract Surgical, Advanced Respiratory, Inc. and at Vital Signs. Reuvers currently serves on the boards of Etac Group and Peerbridge Health. In connection with his employment, Reuvers received an inducement grant of 1,500,000 restricted stock units vesting in substantially equal installments on the first, second, and third anniversary of Reuvers' start date. The grant was approved by the company's Board of Directors and was made as a material inducement to Reuvers' employment with the company.
0 · Reply
DonCorleone77
DonCorleone77 Mar. 17 at 11:55 AM
$STIM Neuronetics sees FY26 revenue $160M-$166M, consensus $164.15M Gross Margin: 47% to 49%; Operating Expenses: $100 million to $105 million, inclusive of approximately $8.5 million of non-cash stock-based compensation; Operating Cash Flow: $(13) million to $(17) million. The Company anticipates a reduction in operating expense in the second half of 2026 as a result of on-going efficiency initiatives and associated investments. By the fourth quarter of 2026, operating expenses are projected to be less than $100 million on an annualized basis. Operating cash flow is expected to improve significantly throughout the year, driven by revenue growth, cost reduction, and continued working capital improvements.
0 · Reply
DARKP00L
DARKP00L Mar. 17 at 11:55 AM
$STIM 07:53 on Mar. 17 2026 Neuronetics Sees FY2026 Sales $160.000M-$166.000M vs $164.167M Est #tradeideas
0 · Reply